Skip to content

The influence of early mobilization to the incidence of delirium in acute uncomlicated type B aortic syndrome

The influence of early mobilization to the incidence of delirium in acute uncomlicated type B aortic syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083034
Enrollment
Unknown
Registered
2024-04-15
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute uncomlicated type B aortic syndrome

Interventions

Experimental group:Routine clinical treatment+early activity therapy

Sponsors

The First Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The age range from 18 to 80; the diagnosis conform to acute type B aortic syndrome, including tpye B intramural hematoma, dissection and penetrating aortic ulcer; the blood pressure is no more than 140/90 mmHg, the heart rate in no more than 80 beats per minute; patients are willing to join this research, sigh their names on the medical informed consent and would like to coopreate with the follow-up.

Exclusion criteria

Exclusion criteria: The oxygen concentration is more than 60%; the pulse oxygen saturation is less than 90%; respiratory rate>30 beats per minute; the blood pressure is less than 90/60mmHg or need an injection of vasopressor drugs; brady cardiac arrhythmia that need to use drugs to boost the heart rate or an implantation of a pacemaker; the lactic acid is more than 4mmol/L; have a diagnosis of acute deep vein embolism or pulmonary embolism; have a diagnosis of severe aortic valve stenosis; have ischemic heart disease (persistent chest pain with dynamic changes in electrocardiogram); have a femoral artery sheath; have a femoral vein sheath; patients are deeply sedated (RASS+2); have delirium and can not cooperate to do specific action; unstable bone fracture; uncontrolled bleeding; in use of anti-arrhythmic drugs; patients who take part in other clincical interventional reseach.

Design outcomes

Primary

MeasureTime frame
Delirium incidence rate;

Secondary

MeasureTime frame
Short Physical Performance Battery, SPPB;SF-12;PHQ-9, GAD-7;All cause mortality rate ;Readmission rate;

Countries

China

Contacts

Public ContactYanping Wang

The First Affiliated Hospital of Shantou University Medical College

ypwang1@126.com+86 159 8983 5385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026